gvtcx

Oncotype DX Breast Recurrence Score test

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£340,200
Statuscomplete
Category (CPV) 85121200
RegionEast of England
Deadline4 Mar 2024
Contract start1 Apr 2024
Contract end31 Mar 2027
Procedureselective
SME suitableNo
OCIDocds-b5fd17-75bfa22a-9754-40c9-b850-df05b7ce9850

Award

SupplierValueDateStatus
Exact Sciences UK, Ltd. £583,200 5 Mar 2024 active

description

System for prognosis of breast cancer recurrence

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
2 Apr 2024 Award (award) · 2d2648c2-1b7e-4be0-a1e1-6f95d7dbfb33-736926

more from Norfolk and Norwich University Hospitals NHS Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.